Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Biomerica, Inc. - SIC # 3840 -
Ticker
Exchange
SIC #
Website
Latest Ticker
BMRA
Nasdaq
3840
www.biomerica.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Biomerica, Inc.
January 2025 US Penny Stocks With Promising Potential
- Jan 17th, 2025 5:04 pm
Biomerica’s prostate cancer detection test gains approval from MOHAP
- Jan 17th, 2025 3:48 pm
Top Midday Gainers
- Jan 16th, 2025 6:01 pm
United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® PSA Screening Test to Detect an Early Sign of Prostate Cancer
- Jan 16th, 2025 1:19 pm
Biomerica Second Quarter 2025 Earnings: US$0.055 loss per share (vs US$0.09 loss in 2Q 2024)
- Jan 16th, 2025 11:07 am
Biomerica Reports Second Quarter Fiscal 2025 Financial Results
- Jan 15th, 2025 1:19 pm
Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn’s Disease, and Ulcerative Colitis
- Nov 21st, 2024 1:19 pm
Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements
- Nov 7th, 2024 2:09 pm
Biomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain
- Oct 30th, 2024 12:19 pm
Biomerica Reports First Quarter Fiscal 2025 Financial Results
- Oct 16th, 2024 1:00 pm
The Saudi Food and Drug Authority (SFDA) Approves Biomerica's At Home PSA Screening Test to Detect Early Signs of Prostate Cancer
- Sep 4th, 2024 12:19 pm
Biomerica Full Year 2024 Earnings: US$0.35 loss per share (vs US$0.50 loss in FY 2023)
- Aug 31st, 2024 1:55 pm
Biomerica Reports Fiscal 2024 Year End Results
- Aug 29th, 2024 1:00 pm
Biomerica Launches At-Home Sample Collection for inFoods® IBS, Significantly Expanding Access for Millions of IBS Sufferers
- Jul 1st, 2024 11:47 am
Biomerica Announces inFoods® IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024
- May 13th, 2024 12:19 pm
Biomerica and Leading UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement
- Apr 29th, 2024 12:19 pm
Biomerica provides update on inFoods® IBS expansion
- Apr 15th, 2024 11:47 am
Biomerica Reports Third Quarter 2024 Financial Results
- Apr 12th, 2024 11:23 pm
Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference
- Mar 28th, 2024 12:19 pm
Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board
- Feb 21st, 2024 1:19 pm
Scroll